One study reported significantly increased concentrations of FGF-23 in patients with advanced ovarian cancer compared to those with early-stage cancer or controls.[7] However, to date, no epidemiological investigations of FGF-23 and risk for colorectal neoplasia have been reported. The gene discussed is FGF23; the disease is ovarian carcinoma.